CO-DIAGNOSTICS, INC. (CODX) Operating cash flow 2016–2025
CO-DIAGNOSTICS, INC. (CODX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$29.1MFY2025 · since FY2016: -$1.3M → -$29.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.1M | +0.1% |
| FY2024 | -$29.2M | -32.0% |
| FY2023 | -$22.1M | -436.2% |
| FY2022 | $6.6M | -84.0% |
| FY2021 | $41.1M | +45.9% |
| FY2020 | $28.2M | +609.8% |
| FY2019 | -$5.5M | -35.4% |
| FY2018 | -$4.1M | -27.0% |
| FY2017 | -$3.2M | -144.7% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Net marginCODX Gross profitCODX Gross marginCODX Operating incomeCODX Operating marginCODX Free cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →